ENOV vs. ORIC

Last updated Jun 4, 2026

ENOV (Enovis Corp) and ORIC (ORIC Pharmaceuticals, Inc.) are both stocks. ENOV operates in Specialty Industrial Machinery (Industrials), while ORIC operates in Biotechnology (Healthcare). Over the past 5 years, ENOV returned -22.84%/yr vs -16.59%/yr for ORIC. At a 0.20 correlation, their price movements are largely independent.

Performance

ENOV vs. ORIC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enovis Corp (ENOV) and ORIC Pharmaceuticals, Inc. (ORIC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ENOV achieves a -19.07% return, which is significantly lower than ORIC's -4.16% return.

ENOV

• 1D: -1.73%
• 1M: -7.63%
• YTD: -19.07%
• 6M: -26.37%
• 1Y: -29.73%
• 3Y*: -27.36%
• 5Y*: -22.84%
• 10Y*: -7.79%

ORIC

• 1D: 2.89%
• 1M: -18.59%
• YTD: -4.16%
• 6M: -28.60%
• 1Y: -6.67%
• 3Y*: 13.80%
• 5Y*: -16.59%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ENOV vs. ORIC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
ENOV Enovis Corp	-19.07%	-39.29%	-21.67%	4.67%	-32.36%	20.21%	65.47%
ORIC ORIC Pharmaceuticals, Inc.	-4.16%	1.36%	-12.28%	56.20%	-59.93%	-56.57%	31.35%

Correlation

The correlation between ENOV and ORIC is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.23
Correlation (All Time) Calculated using the full available price history since Apr 27, 2020	0.20

Fundamentals

EPS ENOV : -$26.70 ORIC : -$1.46
Total Revenue (TTM) ENOV : $2.28B ORIC : $0.00
Gross Profit (TTM) ENOV : $1.38B ORIC : -$320.00K
EBITDA (TTM) ENOV : -$840.37M ORIC : -$140.86M

Return for Risk

ENOV vs. ORIC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENOV

ENOV Risk / Return Rank: 17
ENOV Sharpe Ratio Rank: 17
ENOV Sortino Ratio Rank: 19
ENOV Omega Ratio Rank: 20
ENOV Calmar Ratio Rank: 14
ENOV Martin Ratio Rank: 16

ORIC

ORIC Risk / Return Rank: 39
ORIC Sharpe Ratio Rank: 38
ORIC Sortino Ratio Rank: 42
ORIC Omega Ratio Rank: 44
ORIC Calmar Ratio Rank: 37
ORIC Martin Ratio Rank: 36

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENOV vs. ORIC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enovis Corp (ENOV) and ORIC Pharmaceuticals, Inc. (ORIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ENOV	ORIC	Difference
Sharpe ratio Return per unit of total volatility	-0.55	-0.08	-0.47
Sortino ratio Return per unit of downside risk	-0.53	0.48	-1.01
Omega ratio Gain probability vs. loss probability	0.94	1.07	-0.14
Calmar ratio Return relative to maximum drawdown	-0.74	-0.14	-0.60
Martin ratio Return relative to average drawdown	-1.17	-0.29	-0.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ENOV vs. ORIC - Sharpe Ratio Comparison

The current ENOV Sharpe Ratio is -0.55, which is lower than the ORIC Sharpe Ratio of -0.08. The chart below compares the historical Sharpe Ratios of ENOV and ORIC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ENOV	ORIC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.55	-0.08	-0.47
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.59	-0.19	-0.41
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.18	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.06	-0.20	+0.14

Drawdowns

ENOV vs. ORIC - Drawdown Comparison

The maximum ENOV drawdown since its inception was -83.36%, smaller than the maximum ORIC drawdown of -93.87%. Use the drawdown chart below to compare losses from any high point for ENOV and ORIC.

Drawdown Indicators

	ENOV	ORIC	Difference
Max Drawdown Largest peak-to-trough decline	-83.36%	-93.87%	+10.51%
Max Drawdown (1Y) Largest decline over 1 year	-40.29%	-48.13%	+7.84%
Max Drawdown (3Y) Largest decline over 3 years	-67.26%	-73.46%	+6.20%
Max Drawdown (5Y) Largest decline over 5 years	-76.46%	-90.33%	+13.87%
Max Drawdown (10Y) Largest decline over 10 years	-76.46%	—	—
Current Drawdown Current decline from peak	-83.28%	-80.30%	-2.98%
Average Drawdown Average peak-to-trough decline	-45.92%	-67.74%	+21.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.34%	23.26%	+2.08%

Volatility

ENOV vs. ORIC - Volatility Comparison

The current volatility for Enovis Corp (ENOV) is 19.66%, while ORIC Pharmaceuticals, Inc. (ORIC) has a volatility of 20.73%. This indicates that ENOV experiences smaller price fluctuations and is considered to be less risky than ORIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ENOV	ORIC	Difference
Volatility (1M) Calculated over the trailing 1-month period	19.66%	20.73%	-1.07%
Volatility (6M) Calculated over the trailing 6-month period	39.94%	75.71%	-35.77%
Volatility (1Y) Calculated over the trailing 1-year period	54.08%	80.12%	-26.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	38.61%	90.08%	-51.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.30%	88.10%	-45.80%

Dividends

ENOV vs. ORIC - Dividend Comparison

Neither ENOV nor ORIC has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ENOV and ORIC in my portfolio?

ENOV and ORIC have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ENOV or ORIC?

ORIC has higher volatility (20.73%) compared to ENOV (19.66%). In terms of maximum drawdown, ENOV dropped -83.36% vs ORIC's -93.87%.

Which has better risk-adjusted returns?

ORIC currently has the higher Sharpe Ratio (-0.08 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.